Regulation of vascular tone during pregnancy: A novel role for the pregnane X receptor

Kathryn A. Hagedorn, Christy Lynn Cooke, J R Falck, Bryan F. Mitchell, Sandra T. Davidge

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

During pregnancy, maternal vascular function is altered through mechanisms that remain unclear. Progesterone synthesis and metabolism are also increased. Progesterone metabolites are potent endogenous ligands for the pregnane X receptor (PXR), a nuclear receptor that induces the expression of hepatic cytochrome P450 enzymes. Cytochrome P450 enzymes located in the vasculature can metabolize arachidonic acid to produce epoxyeicosatrienoic acids, known vasodilators. We hypothesized that PXR is present in vascular tissue and contributes to vascular adaptations to pregnancy. PXR mRNA was detected in mouse mesenteric arteries by quantitative RT-PCR. Constrictor and relaxation responses in wildtype (PXR) and PXR-deficient (PXR) mice were compared by wire myography. Relative to nonpregnant controls, arteries from pregnant PXR mice had reduced sensitivity to phenylephrine-induced constriction (EC50: 2.77±0.32 μmol/L versus 5.13±0.36 μmol/L; P=0.009) and enhanced maximal vasorelaxation to bradykinin (26±3% versus 44±16%; P=0.013). However, these pregnancy adaptations were absent in PXR mice. We also hypothesized that PXR is activated by progesterone metabolites. Treatment of PXR and PXR nonpregnant mice with 5β-dihydroprogesterone for 7 days enhanced endothelium-dependent relaxation in only the PXR mice, similarly to that seen in pregnancy. In treated mice, inhibition of cytochrome P450 epoxygenase activity with N-methylsulphonyl-6-(2-propargyloxyphenyl)hexanamide attenuated vasorelaxation in arteries from PXR but not PXR mice. We conclude that PXR contributes to the development of vascular adaptations to pregnancy, likely in response to activation by progesterone metabolites, and that PXR-dependent increases in vasorelaxation may be because of activation of cytochrome P450 epoxygenases.

Original languageEnglish (US)
Pages (from-to)328-333
Number of pages6
JournalHypertension
Volume49
Issue number2
DOIs
StatePublished - Feb 2007

Fingerprint

Blood Vessels
Pregnancy
Cytochrome P-450 Enzyme System
Progesterone
Vasodilation
pregnane X receptor
Myography
Arteries
20-alpha-Dihydroprogesterone
Mesenteric Arteries
Bradykinin
Phenylephrine
Cytoplasmic and Nuclear Receptors
Vasodilator Agents
Arachidonic Acid
Constriction
Endothelium
Mothers

Keywords

  • Cytochrome P450
  • Pregnancy
  • Pregnane X receptor
  • Vascular tone

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Regulation of vascular tone during pregnancy : A novel role for the pregnane X receptor. / Hagedorn, Kathryn A.; Cooke, Christy Lynn; Falck, J R; Mitchell, Bryan F.; Davidge, Sandra T.

In: Hypertension, Vol. 49, No. 2, 02.2007, p. 328-333.

Research output: Contribution to journalArticle

Hagedorn, Kathryn A. ; Cooke, Christy Lynn ; Falck, J R ; Mitchell, Bryan F. ; Davidge, Sandra T. / Regulation of vascular tone during pregnancy : A novel role for the pregnane X receptor. In: Hypertension. 2007 ; Vol. 49, No. 2. pp. 328-333.
@article{08023cc9ed584ace83d6fcff309648d8,
title = "Regulation of vascular tone during pregnancy: A novel role for the pregnane X receptor",
abstract = "During pregnancy, maternal vascular function is altered through mechanisms that remain unclear. Progesterone synthesis and metabolism are also increased. Progesterone metabolites are potent endogenous ligands for the pregnane X receptor (PXR), a nuclear receptor that induces the expression of hepatic cytochrome P450 enzymes. Cytochrome P450 enzymes located in the vasculature can metabolize arachidonic acid to produce epoxyeicosatrienoic acids, known vasodilators. We hypothesized that PXR is present in vascular tissue and contributes to vascular adaptations to pregnancy. PXR mRNA was detected in mouse mesenteric arteries by quantitative RT-PCR. Constrictor and relaxation responses in wildtype (PXR) and PXR-deficient (PXR) mice were compared by wire myography. Relative to nonpregnant controls, arteries from pregnant PXR mice had reduced sensitivity to phenylephrine-induced constriction (EC50: 2.77±0.32 μmol/L versus 5.13±0.36 μmol/L; P=0.009) and enhanced maximal vasorelaxation to bradykinin (26±3{\%} versus 44±16{\%}; P=0.013). However, these pregnancy adaptations were absent in PXR mice. We also hypothesized that PXR is activated by progesterone metabolites. Treatment of PXR and PXR nonpregnant mice with 5β-dihydroprogesterone for 7 days enhanced endothelium-dependent relaxation in only the PXR mice, similarly to that seen in pregnancy. In treated mice, inhibition of cytochrome P450 epoxygenase activity with N-methylsulphonyl-6-(2-propargyloxyphenyl)hexanamide attenuated vasorelaxation in arteries from PXR but not PXR mice. We conclude that PXR contributes to the development of vascular adaptations to pregnancy, likely in response to activation by progesterone metabolites, and that PXR-dependent increases in vasorelaxation may be because of activation of cytochrome P450 epoxygenases.",
keywords = "Cytochrome P450, Pregnancy, Pregnane X receptor, Vascular tone",
author = "Hagedorn, {Kathryn A.} and Cooke, {Christy Lynn} and Falck, {J R} and Mitchell, {Bryan F.} and Davidge, {Sandra T.}",
year = "2007",
month = "2",
doi = "10.1161/01.HYP.0000253478.51950.27",
language = "English (US)",
volume = "49",
pages = "328--333",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Regulation of vascular tone during pregnancy

T2 - A novel role for the pregnane X receptor

AU - Hagedorn, Kathryn A.

AU - Cooke, Christy Lynn

AU - Falck, J R

AU - Mitchell, Bryan F.

AU - Davidge, Sandra T.

PY - 2007/2

Y1 - 2007/2

N2 - During pregnancy, maternal vascular function is altered through mechanisms that remain unclear. Progesterone synthesis and metabolism are also increased. Progesterone metabolites are potent endogenous ligands for the pregnane X receptor (PXR), a nuclear receptor that induces the expression of hepatic cytochrome P450 enzymes. Cytochrome P450 enzymes located in the vasculature can metabolize arachidonic acid to produce epoxyeicosatrienoic acids, known vasodilators. We hypothesized that PXR is present in vascular tissue and contributes to vascular adaptations to pregnancy. PXR mRNA was detected in mouse mesenteric arteries by quantitative RT-PCR. Constrictor and relaxation responses in wildtype (PXR) and PXR-deficient (PXR) mice were compared by wire myography. Relative to nonpregnant controls, arteries from pregnant PXR mice had reduced sensitivity to phenylephrine-induced constriction (EC50: 2.77±0.32 μmol/L versus 5.13±0.36 μmol/L; P=0.009) and enhanced maximal vasorelaxation to bradykinin (26±3% versus 44±16%; P=0.013). However, these pregnancy adaptations were absent in PXR mice. We also hypothesized that PXR is activated by progesterone metabolites. Treatment of PXR and PXR nonpregnant mice with 5β-dihydroprogesterone for 7 days enhanced endothelium-dependent relaxation in only the PXR mice, similarly to that seen in pregnancy. In treated mice, inhibition of cytochrome P450 epoxygenase activity with N-methylsulphonyl-6-(2-propargyloxyphenyl)hexanamide attenuated vasorelaxation in arteries from PXR but not PXR mice. We conclude that PXR contributes to the development of vascular adaptations to pregnancy, likely in response to activation by progesterone metabolites, and that PXR-dependent increases in vasorelaxation may be because of activation of cytochrome P450 epoxygenases.

AB - During pregnancy, maternal vascular function is altered through mechanisms that remain unclear. Progesterone synthesis and metabolism are also increased. Progesterone metabolites are potent endogenous ligands for the pregnane X receptor (PXR), a nuclear receptor that induces the expression of hepatic cytochrome P450 enzymes. Cytochrome P450 enzymes located in the vasculature can metabolize arachidonic acid to produce epoxyeicosatrienoic acids, known vasodilators. We hypothesized that PXR is present in vascular tissue and contributes to vascular adaptations to pregnancy. PXR mRNA was detected in mouse mesenteric arteries by quantitative RT-PCR. Constrictor and relaxation responses in wildtype (PXR) and PXR-deficient (PXR) mice were compared by wire myography. Relative to nonpregnant controls, arteries from pregnant PXR mice had reduced sensitivity to phenylephrine-induced constriction (EC50: 2.77±0.32 μmol/L versus 5.13±0.36 μmol/L; P=0.009) and enhanced maximal vasorelaxation to bradykinin (26±3% versus 44±16%; P=0.013). However, these pregnancy adaptations were absent in PXR mice. We also hypothesized that PXR is activated by progesterone metabolites. Treatment of PXR and PXR nonpregnant mice with 5β-dihydroprogesterone for 7 days enhanced endothelium-dependent relaxation in only the PXR mice, similarly to that seen in pregnancy. In treated mice, inhibition of cytochrome P450 epoxygenase activity with N-methylsulphonyl-6-(2-propargyloxyphenyl)hexanamide attenuated vasorelaxation in arteries from PXR but not PXR mice. We conclude that PXR contributes to the development of vascular adaptations to pregnancy, likely in response to activation by progesterone metabolites, and that PXR-dependent increases in vasorelaxation may be because of activation of cytochrome P450 epoxygenases.

KW - Cytochrome P450

KW - Pregnancy

KW - Pregnane X receptor

KW - Vascular tone

UR - http://www.scopus.com/inward/record.url?scp=33846428071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846428071&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.0000253478.51950.27

DO - 10.1161/01.HYP.0000253478.51950.27

M3 - Article

C2 - 17159084

AN - SCOPUS:33846428071

VL - 49

SP - 328

EP - 333

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 2

ER -